Short interest in Emergent BioSolutions Inc (NYSE:EBS) increased during the last reporting period, rising from 6.93M to 7.09M. This put 15.91% of the company's publicly available shares short.
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback